Predictors of Development of Diabetes Mellitus in Patients With Coronary Artery Disease Taking Antihypertensive Medications (Findings from the INternational VErapamil SR-Trandolapril STudy [INVEST])
Authors:
- Jerome D. CohenJCJerome D. Cohen
- George L. BakrisGBGeorge L. Bakris
- Franz H. MesserliFMFranz H. Messerli
- Serap ErdineSESerap Erdine
- Ann C. HewkinAHAnn C. Hewkin
- Stuart KupferSKStuart Kupfer
- Carl J. PepineCPCarl J. Pepine
- 1 October 2006
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 98 (7) , 890-894
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- A Drug Dose Model for Predicting Clinical Outcomes in Hypertensive Coronary Disease PatientsThe Journal of Clinical Hypertension, 2005
- Should Diabetes Be Considered a Coronary Heart Disease Risk Equivalent?Diabetes Care, 2005
- Use of the Diabetes Risk Score for Opportunistic Screening of Undiagnosed Diabetes and Impaired Glucose ToleranceDiabetes Care, 2005
- Clinical Outcomes in the Diabetes Cohort of the International Verapamil SR-Trandolapril StudyHypertension, 2004
- Cardiovascular Therapies and Risk for Development of DiabetesJACC, 2004
- Adverse Prognostic Significance of New Diabetes in Treated Hypertensive SubjectsHypertension, 2004
- A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery DiseaseJAMA, 2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertensionJACC, 1998
- The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureArchives of internal medicine (1960), 1997